Complete our Fin24 survey and stand a chance to win R3 000.
Peter Montalto looks at the issues around Amcu's strike.
The union may be on a straight course for a steep precipice, says Leopold Scholtz.
Drugmaker GlaxoSmithKline - hit by bribery claims in five countries - is to employ hundreds more doctors as it seeks to build a new sales model.
GlaxoSmithKline is facing a criminal investigation in Poland for allegedly
bribing doctors to promote its lung drug Seretide.
Investors are confident that Sun Pharma's $3.2bn purchase of rival Ranbaxy is a great deal, banking on Sun's history of nursing ailing companies back to health.
Governments who stockpile Roche's flu medicine Tamiflu are wasting billions on a drug whose effectiveness is in doubt, researchers say.
Resolutions have been passed at an extraordinary general meeting of Adcock Ingram shareholders to appoint three new board members.
The World Health Organisation wants a "concerted effort" to drive down the cost of new hepatitis C drugs that offer a cure for the liver-destroying virus.
Sun Pharma has announced a $3.2bn deal to buy the larger and troubled Ranbaxy from Daiichi Sankyo, ending the Japanese company's costly run as owner.
Indian drug company Biocon has rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for a diabetes drug.
Shares in Adcock Ingram hardly moved after naming industry newcomer Kevin Wakeford as its new chief executive.
Adcock Ingram has named an industry newcomer and a veteran executive from its top shareholder as its new head.
There is less than one laboratory professional per 10 000 people in Africa, says the African Society for Laboratory Medicine.
Taxpayers must ensure their Sars affairs are in order.
Advice for a Fin24 user on how to deal with an incompetent debt counsellor.
A user has observed shrinkflation since the1970s and says it's nothing new.
A Fin24 user overcame his unemployment crisis by taking matters into his own hands.
Advice for a user who is battling with clients paying late or withholding payment.
A Fin24 user wants to sell his house to escape the debt monster.
Biotechnologist Ashley Uys is one of Forbes' 30 Most Promising Young Entrepreneurs.
A user is way more in debt despite having been under debt review for years.
Doctors in Britain were paid $64m by drugmakers last year, according to new data underscoring the links between the pharmaceutical industry and prescribers.
French multinational pharmaceutical company Sanofi is on the lookout for acquisitions to boost key business units and expects strong growth in Africa.
The latter few weeks of election 2014, have seen South Africans reeling from an assault on their comfort zone when it comes to voting, writes Daniel Silke
Create more jobs
Help grow the Gauteng economy
Lead to a Chinese invasion
I don't care
Previous results ·
Suggest a vote
Get your financial questions answered.
News delivered really simply.
Easy-to-use personal finance tools.
You choose what you want.
Your opinion on you, me and everyone.
Get us in your home, on your television.
Lost? Confused? Problems? Let us help you.